Northwell Health: Feinstein Institutes Begins Enrolling Patients in Multiple COVID-19 Clinical Trials
March 21, 2020
March 21, 2020
MANHASSET, New York, March 21 -- Northwell Health issued the following news:
The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus.
Feinstein Institutes researchers are teaming up with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi to identify effective treatments for patients currently hospitalized in moderate and sever . . .
The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus.
Feinstein Institutes researchers are teaming up with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi to identify effective treatments for patients currently hospitalized in moderate and sever . . .